Cardiol Therapeutics Signs Exclusive National Supplier Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart

Investors

Press Releases

Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”

December 20, 2018

Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel

August 30, 2018

Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors

August 21, 2018

Cardiol Therapeutics Closes $10.5 Million Private Placement

May 24, 2018

Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board

May 08, 2018

Cardiol Therapeutics to Present at the 2018 BIO CEO & Investor Conference in NYC

February 06, 2018

Cardiol Therapeutics Demonstrates Novel Way to Target Drugs for Treating Heart Failure Using Nanotechnology

January 09, 2018

Cardiol Therapeutics to Present at the 2018 Biotech Showcase in San Francisco

January 03, 2018

Cardiol Therapeutics Appoints Bruce Hirsche and Peter Pekos to Board of Directors

December 15, 2017

Cardiol Signs Letter of Intent with TecSalud and Nano4heart for the Development of Heart Failure Therapies

November 17, 2017